Sample banner

The KEMRI – Defense Threat Reduction Agency (DTRA)/Cooperative Biological Engagement Program (CBEP) Collaborative Project was informed by an agreement signed during the visit to Kenya by the former United States of America (USA) President, Barack Obama, between his government and the Government of Kenya (GOK) concerning Cooperation in Threat Reduction Biological Engagement Programs.

This collaborative engagement will see the construction of a Sample Management and Receiving Facility (SMRF) building, the construction of a two-storey office connector building and the construction of two, two-story multi-purpose conference rooms.

It also involves the purchase, installation, and commissioning of two new biomedical waste incinerators; installation of three new insectaries; renovations of selected laboratory and office spaces; training and capacity building of KEMRI personnel in line with biosafety, biosecurity and the provision of Pathogen Asset Control System (PACS) and capacity building to operate and utilize the system for sample management.

As a national institution responsible for conducting human health research in Kenya and with a mandate to provide solutions for health problems affecting the Kenyan public, KEMRI’s mandate includes the isolation, handling, storage and discarding of proliferative dangerous pathogens (biological) and the handling of dangerous chemicals used in research affecting human life.

At the moment, preparations and designs of the agreed construction and renovations of the selected laboratory and office space is not only complete, but also agreed upon by the two parties; KEMRI and DTRA.

It is against this background that the DTRA team paid a courtesy call to Director KEMRI on Tuesday, May 2nd, 2017 to finalize on arrangements to begin the project, expected to begin before the end of this May 2017.


From left to right, Ministry of Health Official, Ms. Isabella Agaya, Acting Director KEMRI, Dr. Yeri Kombe, Lance Brooks and Capt. David Waddell from DTRA CBEP during a kick off meeting a head of the planned ground breaking ceremony for the construction of laboratory biosafety and biosecurity upgrades at KEMRI.

 

loader

Upcoming Events

No events found

Dr. Kombe takes over as Acting Director KEMRI

Sample image


Veteran medical research scientist and public health expert Dr. Yeri Israel Kombe has been appointed as the Acting Chief Executive Officer and Director of the Kenya Medical Research Institute (KEMRI).

Dr. Kombe who takes over from Dr. Gerald Mkoji who has been acting in a similar position since December 2015.

In a letter dated 28th March 2017 addressed to Dr. Kombe, the Cabinet Secretary of Health,Dr. Cleopa Mailu informed that the appointment was with effect from 1st April, 2017.



 

New guidelines on HIV self-testing released

Sample image


Lack of effective HIV diagnosis has grossly hampered the fight against HIV, the World Health Organization (WHO) has said.

Consequently, as the World Aids Day is observed today, the WHO, has released new guidelines on HIV self-testing aimed at improving access to and uptake of HIV diagnosis

In a special report released Tuesday, 29th November, 2016, reveals that more than 18 million people with HIV are currently taking ART



 

KEMRI on Twitter

KEMRI on Facebook

Research Programmes

  • Biotechnology. jpg.jpg
  • Infectious and Parasitic Disease.jpg.jpg
  • natural products.jpg
  • Non- Communicable.jpg
  • Public Health and Health Systems jpg.jpg
  • Sexual, Reproductive, Adolesent & Child Health. jp.jpg

KEMRI has six (6) Main Programmes aligned to the KEMRI Strategic Master plan and the Vision 2030.

Upcoming Events

Sample image


The 4th Annual PAMCA Conference, scheduled for October 16th-18th, 2017, Nairobi.

Asymptomatic Malaria



Dr. Bernahards Ogutu and Lorraine de Beer talk on Asymptomatic Malaria as the World prepares to mark #WorldMalariaDay

Ebola Virus

Sample image


Researchers at the Kemri-wellcome trust in Kilifi Kenya have completed the enromllment in a trial of a vaccine designed to protect against ebola.